How AI Will Make Our Lives Better (And Worse)
May 31, 2023・By David H. Freedman・Newsweek Magazine The explosion of progress in artificial intelligence in recent months has surprised even...
AI-discovered drug shows ‘enormous potential’ to treat schizophrenia: ‘Real need for better treatment’
May 9, 2023・By Angelica Stabile・Fox News PsychoGenics CEO reveals how machine learning has enabled new steps toward addressing mental disorder As...
PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery
April 6, 2023・Businesswire PARAMUS, N.J.–(BUSINESS WIRE)–PsychoGenics Inc. (“PsychoGenics” or the “Company”), a leader in AI-enabled phenotypic drug discovery and preclinical CRO...
PsychoGenics highlights a long-term collaboration with the TSC Alliance on Rare Disease Day
Feb. 28, 2023 On this Rare Disease Day, we want to highlight and honor our long-term collaboration with the TSC...
PsychoGenics CEO explores CNS drug development trends
February 4, 2023 · By Brian Buntz · Drug Discovery & Development In the late 2000s, many companies, particularly Big...
Why the TAAR1 agonist ulotaront holds promise for schizophrenia
November 22, 2022 · By Brian Buntz · Drug Discovery & Development Ulotaront (SEP-363856), a trace amine-associated receptor 1 (TAAR1)...
A novel phenotypic approach to CNS drug discovery
November 10, 2022 · Drug Discovery World The newest addition to the free DDW podcast is the In Conversation With series, where...
4 next-gen CNS drug development trends
By Brian Buntz · October 24, 2022 · Drug Discovery & Development The past couple of years have had a significant...
Why Psychogenics and Emyria are collaborating to examine MDMA-inspired compounds
By Brian Buntz · Oct 12, 2022 · Drug Discovery & Development CNS-focused contract research organization PsychoGenics has forged a collaboration with clinical-stage...
PsychoGenics Announces Extension of Ongoing Drug Discovery Collaboration with Karuna Therapeutics
Oct 11, 2022 · Business Wire PARAMUS, N.J.–(BUSINESS WIRE)–PsychoGenics Inc. (“PsychoGenics” or the “Company”), a leader in AI-enabled phenotypic drug discovery and...